OptimizeRx Corporation (OPRX) has a MoatMap StockRank of 72/100 based on Quality (68/100), Value (68/100), and Momentum (20/100) factor scores. The current signal is BUY. OptimizeRx is a micro-cap digital health platform. Despite a decent quality score of 68, its extremely low momentum score of 19 and small scale make it highly risky, with no clear alignment to our core macro themes.
OptimizeRx Corporation is a digital health technology company that connects pharmaceutical manufacturers with healthcare providers and patients at the point of care. The company's platform integrates directly into electronic health record (EHR) and e-prescribing workflows, creating a high-barrier-to-entry distribution network. Its competitive moat lies in its ability to deliver targeted clinical and financial information to physicians in real time.
| Price | $5.07 |
| Market Cap | $96M |
| P/E (TTM) | 14.94 |
| P/E (Forward) | 5.09 |
| Price/Book | 0.79 |
| Return on Equity | 5.6% |
| Return on Invested Capital | 7.9% |
| Debt/Equity | 18.30 |
| Gross Margin | 70.0% |
| Operating Margin | 2.0% |
| Revenue Growth | -9.5% |
| Free Cash Flow | $11M |
OptimizeRx Corporation operates in the Health Information Services industry, part of the Healthcare sector (United States).